Graphene quantum dots blocking the channel egresses of cytochrome P450 enzyme (CYP3A4) reveals potential toxicity.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 Nov 2023
Historique:
received: 20 10 2023
accepted: 28 11 2023
medline: 4 12 2023
pubmed: 1 12 2023
entrez: 30 11 2023
Statut: epublish

Résumé

Graphene quantum dots (GQDs) have garnered significant attention, particularly in the biomedical domain. However, extensive research reveals a dichotomy concerning the potential toxicity of GQDs, presenting contrasting outcomes. Therefore, a comprehensive understanding of GQD biosafety necessitates a detailed supplementation of their toxicity profile. In this study, employing a molecular dynamics (MD) simulation approach, we systematically investigate the potential toxicity of GQDs on the CYP3A4 enzyme. We construct two distinct simulation systems, wherein a CYP3A4 protein is enveloped by either GQDs or GOQDs (graphene oxide quantum dots). Our results elucidate that GQDs come into direct contact with the bottleneck residues of Channels 2a and 2b of CYP3A4. Furthermore, GQDs entirely cover the exits of Channels 2a and 2b, implying a significant hindrance posed by GQDs to these channels and consequently leading to toxicity towards CYP3A4. In-depth analysis reveals that the adsorption of GQDs to the exits of Channels 2a and 2b is driven by a synergistic interplay of hydrophobic and van der Waals (vdW) interactions. In contrast, GOQDs only partially obstruct Channel 1 of CYP3A4, indicating a weaker influence on CYP3A4 compared to GQDs. Our findings underscore the potential deleterious impact of GQDs on the CYP3A4 enzyme, providing crucial molecular insights into GQD toxicology.

Identifiants

pubmed: 38036640
doi: 10.1038/s41598-023-48618-z
pii: 10.1038/s41598-023-48618-z
pmc: PMC10689800
doi:

Substances chimiques

Graphite 7782-42-5
Cytochrome P-450 CYP3A EC 1.14.14.1
Cytochrome P-450 Enzyme System 9035-51-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21091

Subventions

Organisme : Basic and Applied Basic Research Foundation of Guangdong Province
ID : 2022A1515220075
Organisme : National Natural Science Foundation of China
ID : 12104394

Informations de copyright

© 2023. The Author(s).

Références

Biomaterials. 2019 Feb;194:215-232
pubmed: 30578043
J Appl Toxicol. 2017 Oct;37(10):1140-1150
pubmed: 28418071
Chem Res Toxicol. 2012 Jan 13;25(1):15-34
pubmed: 21954945
J Mol Model. 2010 Apr;16(4):607-14
pubmed: 19727863
Sci Rep. 2015 Jun 02;5:10873
pubmed: 26034971
J Phys Chem B. 1998 Apr 30;102(18):3586-616
pubmed: 24889800
Nat Nanotechnol. 2008 Apr;3(4):210-5
pubmed: 18654505
ACS Nano. 2015 Jan 27;9(1):663-9
pubmed: 25494677
Nanomedicine (Lond). 2018 Aug 1;13(15):1923-1937
pubmed: 30124363
Sci Rep. 2016 Feb 22;6:21316
pubmed: 26899743
Toxicol Lett. 1994 Feb 1;70(2):133-8
pubmed: 8296317
Part Fibre Toxicol. 2016 Oct 31;13(1):57
pubmed: 27799056
Chem Res Toxicol. 2008 Jan;21(1):70-83
pubmed: 18052394
Science. 2004 Oct 22;306(5696):666-9
pubmed: 15499015
ACS Nano. 2011 Sep 27;5(9):6971-80
pubmed: 21851105
Science. 2009 Jun 19;324(5934):1530-4
pubmed: 19541989
ACS Nano. 2010 Oct 26;4(10):5731-6
pubmed: 20925398
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Biochim Biophys Acta. 2007 Mar;1770(3):390-401
pubmed: 16920266
Science. 1999 Jul 2;285(5424):91-3
pubmed: 10390369
Nanomedicine (Lond). 2011 Feb;6(2):317-24
pubmed: 21385134
ACS Appl Mater Interfaces. 2021 Jun 23;13(24):27784-27795
pubmed: 34126740
Clin Pharmacol Ther. 2018 Sep;104(3):515-524
pubmed: 29205295
Chem Rev. 2013 May 8;113(5):3407-24
pubmed: 23452512
Nano Lett. 2012 Mar 14;12(3):1482-5
pubmed: 22332750
Biomaterials. 2014 Jun;35(19):5041-8
pubmed: 24685264
Biomaterials. 2015 Feb;40:12-22
pubmed: 25498801
Nanoscale. 2015 Dec 21;7(47):19949-57
pubmed: 26419315
Adv Mater. 2019 May;31(21):e1808283
pubmed: 30828898
Nat Nanotechnol. 2013 Aug;8(8):594-601
pubmed: 23832191
Drug Metab Dispos. 2004 Nov;32(11):1201-8
pubmed: 15304429
J Mater Chem B. 2014 Jun 28;2(24):3849-3859
pubmed: 32261731
Nano Lett. 2010 Sep 8;10(9):3318-23
pubmed: 20684528
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
ACS Nano. 2010 Jul 27;4(7):4317-23
pubmed: 20593851
Nanoscale. 2014 Jun 7;6(11):5799-806
pubmed: 24740121
Small. 2022 Jan;18(2):e2102683
pubmed: 34549513
Toxicology. 2015 Jan 2;327:62-76
pubmed: 25446327
Small. 2013 May 27;9(9-10):1492-503
pubmed: 22987582
PLoS One. 2015 Dec 28;10(12):e0144906
pubmed: 26709828

Auteurs

Yuqi Luo (Y)

Department of Gastrointestinal and Hepatobiliary Surgery, Shenzhen Longhua District Central Hospital, No. 187, Guanlan Road, Longhua District, Shenzhen, 518110, Guangdong Province, China. luoyuqi2004@tom.com.

Jinjun Li (J)

Department of Gastrointestinal and Hepatobiliary Surgery, Shenzhen Longhua District Central Hospital, No. 187, Guanlan Road, Longhua District, Shenzhen, 518110, Guangdong Province, China.

Zonglin Gu (Z)

College of Physical Science and Technology, Yangzhou University, Jiangsu, 225009, China.

Yaoxing Huang (Y)

Department of Gastrointestinal and Hepatobiliary Surgery, Shenzhen Longhua District Central Hospital, No. 187, Guanlan Road, Longhua District, Shenzhen, 518110, Guangdong Province, China. huangyaoxing@sina.com.
Department of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong Province, China. huangyaoxing@sina.com.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics

Classifications MeSH